Evidence map›Paper›PMID 23323900›Full record

ArticleThe New England journal of medicine2013

Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient.

Joseph L Gugliotta, Heidi K Goethert, Victor P Berardi, Sam R Telford

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The New England journal of medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed, 4 pooled it
23.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 4 syntheses or guidelines pooled it, 274 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Lyme Disease and Other Tick-Borne Infections.Current neurology and neuroscience reports · 2026
    Review
  6. Tropical medicine and infectious disease · 2026
    Article
  7. Review
  8. Article
  9. Analytical comparison of 11 CE-IVD marked real-time PCR assays for Borrelia burgdorferi sensu lato detection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  10. Review
  11. Article
  12. Tick-induced neurological disorders.Journal of neurology · 2025
    Review
  13. Review
  14. Infection and immunity · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Prevalence of Lyme Disease and Relapsing FeverPathogens (Basel, Switzerland) · 2024
    Review
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Joseph L GugliottaDepartment of Internal Medicine, Division of Infectious Disease, Hunterdon Medical Center, Flemington, New Jersey, USA.
Heidi K Goethert
Victor P Berardi
Sam R Telford
Johnson University · USTufts University · US

Funding

Xenodiagnosis of Lyme DiseaseR21AI082436 · NIAID · TUFTS MEDICAL CENTER · PI HU, LINDEN T · 2009 to 2012
$629k
Delivery system development for a reservoir targeted Lyme disease vaccineR41AI078631 · NIAID · FOODSOURCE LURE CORPORATION · PI HU, LINDEN T · 2008 to 2009
$600k
NIAID NIH HHS R21 AI 082436NIAID NIH HHS R21 AI082436NIAID NIH HHS R41 AI 078631NIAID NIH HHS R41 AI078631
6 · The paper itself

Abstract

Ixodes ticks serve as vectors for Borrelia burgdorferi, the agent of Lyme disease. Globally, these ticks often concurrently harbor B. miyamotoi, a spirochete that is classified within the relapsing-fever group of spirochetes. Although humans presumably are exposed to B. miyamotoi, there are limited data suggesting disease attributable to it. We report a case of progressive mental deterioration in an older, immunocompromised patient, and even though Koch's postulates were not met, we posit B. miyamotoi as the cause, owing to its direct detection in cerebrospinal fluid (CSF) with the use of microscopy and a polymerase-chain-reaction (PCR) assay. It is likely that B. miyamotoi is an underrecognized cause of disease, especially in sites where Lyme disease is endemic.

Indexed as

Immunocompromised HostAged, 80 and overBorreliaBorrelia InfectionsCerebrospinal FluidCognition DisordersFemaleHumansMeningoencephalitisPhylogenyPolymerase Chain Reaction

Identifiers

PMID23323900
PMCPMC4018741
OpenAlexW1971221639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.